Dr. Petra E. Duran-Gehring, MD

Dr. Duran-Gehring practices at UF Health Jacksonville in Jacksonville, Florida, part of UF Health.

Dr. Duran-Gehring's NPI, 1720198450, was assigned on August 30, 2006. Dr. Duran-Gehring graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2001. Dr. Duran-Gehring holds Florida license ME91161.

Dr. Duran-Gehring's primary practice is UF Health Jacksonville, at 655 W 8th St, Jacksonville, FL 32209 in Duval County. The practice phone is (904) 244-4000.

Dr. Duran-Gehring's primary practice is UF Health Jacksonville in Jacksonville, Florida, part of UF Health. The medical group on file is UF Jacksonville Physicians, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duran-Gehring practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Duran-Gehring's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Duran-Gehring is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Duran-Gehring's licenses on file in 3 states: Florida, California and Georgia.

CMS data shows 71 Medicare services from Dr. Duran-Gehring across 4 procedure codes in 2024, for 77 Medicare patients. Medicare paid $7,935 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Dr. Duran-Gehring in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Duran-Gehring's median patient age at 61, with 52% women.

In 2024, Dr. Duran-Gehring wrote 39 Medicare Part D claims for 29 patients. 90% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $77 in total drug cost. In 2016, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Duran-Gehring for performance year 2024, reported through an alternative payment model (APM). Dr. Duran-Gehring accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Duran-Gehring, published from 2014 to 2025. The most frequent topics are Emergency Service, Hospital and Ultrasonography, Interventional. Dr. Duran-Gehring's most frequent co-authors are Faheem Wagid Guirgis, MD, Laurie Susan Bryant, DO and Steven L. Chadwick, DO.

CMS Open Payments shows 6 general payments to Dr. Duran-Gehring from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. FUJIFILM SonoSite, Inc. paid the most, $244. It also lists 1 research payment totaling $8,755 in 2024.

Dr. Duran-Gehring graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2001.

Dr. Duran-Gehring is in network with 5 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.